D'ambrosio Eye Care, Inc. - Medicare in Lancaster, MA

D'ambrosio Eye Care, Inc. is a medicare enrolled "Ophthalmology" provider in Lancaster, Massachusetts. Their current practice location is 479 Old Union Tpke, Lancaster, Massachusetts. You can reach out to their office (for appointments etc.) via phone at (978) 537-3900.

D'ambrosio Eye Care, Inc. is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. D'ambrosio Eye Care, Inc. is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1922020874.

Contact Information

D'ambrosio Eye Care, Inc.
479 Old Union Tpke,
Lancaster, MA 01523-3029
(978) 537-3900
(978) 537-6030



Healthcare Provider's Profile

Full NameD'ambrosio Eye Care, Inc.
TypeFacility
SpecialityOphthalmology
Location479 Old Union Tpke, Lancaster, Massachusetts
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1922020874
  • Provider Enumeration Date: 07/23/2006
  • Last Update Date: 04/27/2009
  Medicare PECOS Information:
  • PECOS PAC ID: 5597755314
  • Enrollment ID: O20040514000021

Medical Identifiers

Medical identifiers for D'ambrosio Eye Care, Inc. such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1922020874NPI-NPPES
9762604MedicaidMA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (* (Not Available))Secondary
207W00000XOphthalmology (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. D'ambrosio Eye Care, Inc. acts as a billing entity for following providers:
Provider NameOren L Weisberg
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1427079995
PECOS PAC ID: 9537067467
Enrollment ID: I20031230000080

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameJohn J Marabello
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1326069899
PECOS PAC ID: 7810948429
Enrollment ID: I20050201000444

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameFrancis A Dambrosio
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1497789754
PECOS PAC ID: 5395643225
Enrollment ID: I20050825000844

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameRichard C Erickson
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1932120409
PECOS PAC ID: 0345255840
Enrollment ID: I20060220000205

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameMichael M Fu
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1154342624
PECOS PAC ID: 7416962915
Enrollment ID: I20060220000220

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameAlan P Moss
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1962502427
PECOS PAC ID: 3476567090
Enrollment ID: I20060418000384

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameBin Wu
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1437132529
PECOS PAC ID: 7214920297
Enrollment ID: I20090917000326

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameMeritza Kluge
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1134450752
PECOS PAC ID: 6608901525
Enrollment ID: I20100317000887

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameJoann C Chang
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1730359100
PECOS PAC ID: 0345314472
Enrollment ID: I20100715000859

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameKhyla E Osaretin
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1235374182
PECOS PAC ID: 2264616309
Enrollment ID: I20110413000892

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameSara Anne Apollonio
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1427338755
PECOS PAC ID: 2264681303
Enrollment ID: I20121004000198

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameToral Patel
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1598014607
PECOS PAC ID: 9638329592
Enrollment ID: I20121030000566

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameSandra Y Hu-torres
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1891091153
PECOS PAC ID: 9032380498
Enrollment ID: I20121101000277

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameKun Nancy Wu
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1184008187
PECOS PAC ID: 8426365313
Enrollment ID: I20150909001424

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameJudy Bavongkhoun
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1104374628
PECOS PAC ID: 7214216639
Enrollment ID: I20161108000259

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameJacqueline Rae Renteria
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1457651010
PECOS PAC ID: 7719250315
Enrollment ID: I20170901001673

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameBrenda Komari
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1588154835
PECOS PAC ID: 3072861087
Enrollment ID: I20180808001655

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameElite Bor-shavit
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1104303858
PECOS PAC ID: 3971840711
Enrollment ID: I20190131002789

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameIsaiah W Giese
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1235544933
PECOS PAC ID: 6709199326
Enrollment ID: I20211210000286

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameNatasha H Siegel
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1710573118
PECOS PAC ID: 1456741263
Enrollment ID: I20211210001050

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NameShudeshna T Chen
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1275108722
PECOS PAC ID: 0648666321
Enrollment ID: I20220405002527

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Provider NamePrinal M Patel
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1871274522
PECOS PAC ID: 3971965310
Enrollment ID: I20230816002321

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. D'ambrosio Eye Care, Inc. is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
D'ambrosio Eye Care, Inc.
479 Old Union Tpke,
Lancaster, MA 01523-3029

Ph: (978) 537-3900
D'ambrosio Eye Care, Inc.
479 Old Union Tpke,
Lancaster, MA 01523-3029

Ph: (978) 537-3900

News Archive

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

British doctors support Appeal Court ruling on end of life guidance

The British Medical Association (BMA) is supporting today's Appeal Court Ruling on the GMC's guidance: 'Withholding and withdrawing life-prolonging treatment: good practice in decision-making'.

Pediatric Infectious Disease Journal review: COVID-19 appears less severe in children

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there's reassuring evidence that children have fewer symptoms and less severe disease.

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

Read more News

› Verified 9 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.